[go: up one dir, main page]

RU2002120894A - A method for the treatment of post-inflammatory bullous keratopathy - Google Patents

A method for the treatment of post-inflammatory bullous keratopathy

Info

Publication number
RU2002120894A
RU2002120894A RU2002120894/14A RU2002120894A RU2002120894A RU 2002120894 A RU2002120894 A RU 2002120894A RU 2002120894/14 A RU2002120894/14 A RU 2002120894/14A RU 2002120894 A RU2002120894 A RU 2002120894A RU 2002120894 A RU2002120894 A RU 2002120894A
Authority
RU
Russia
Prior art keywords
inflammatory
post
treatment
bullous keratopathy
keratopathy
Prior art date
Application number
RU2002120894/14A
Other languages
Russian (ru)
Other versions
RU2218896C1 (en
Inventor
Владимир Иванович Братко
Галина Викторовна Братко
Валерий В чеславович Черных
Валерий Вячеславович Черных
Original Assignee
Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирурги глаза" им. акад. С.Н. Федорова
Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирурги глаза" им. акад. С.Н. Федорова, Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова filed Critical Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирурги глаза" им. акад. С.Н. Федорова
Priority to RU2002120894A priority Critical patent/RU2218896C1/en
Application granted granted Critical
Publication of RU2218896C1 publication Critical patent/RU2218896C1/en
Publication of RU2002120894A publication Critical patent/RU2002120894A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (2)

1. Способ лечения поствоспалительной буллезной кератопатии, включающий введение лекарственных средств, отличающийся тем, что введение лекарственных средств осуществляют в лимфатический регион орбиты на стороне пораженного глаза путем выполнения крылонебных блокад, а в качестве лекарственных средств используют лечебную смесь, содержащую лидокаин-20-40 мг, дексазон - 4-8 мг, тауфон - 40-80 мг, даларгин 1-2 мг, лидазу 16-32 ед.акт., воду дистиллированную - 3-6 мл.1. A method of treating post-inflammatory bullous keratopathy, comprising administering drugs, characterized in that the drug is administered into the lymphatic region of the orbit on the side of the affected eye by performing pterygopalatine blockade, and a medicinal mixture containing lidocaine-20-40 mg is used as medicine , dexazone - 4-8 mg, taufon - 40-80 mg, dalargin 1-2 mg, lidase 16-32 units.act., distilled water - 3-6 ml. 2. Способ по п.1, отличающийся тем, что осуществляют 3-6 блокад с интервалом через день.2. The method according to claim 1, characterized in that they carry out 3-6 blockades with an interval every other day.
RU2002120894A 2002-08-07 2002-08-07 Method for treating the cases of post-inflammation bullous keratopathy RU2218896C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002120894A RU2218896C1 (en) 2002-08-07 2002-08-07 Method for treating the cases of post-inflammation bullous keratopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002120894A RU2218896C1 (en) 2002-08-07 2002-08-07 Method for treating the cases of post-inflammation bullous keratopathy

Publications (2)

Publication Number Publication Date
RU2218896C1 RU2218896C1 (en) 2003-12-20
RU2002120894A true RU2002120894A (en) 2004-02-27

Family

ID=32066983

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002120894A RU2218896C1 (en) 2002-08-07 2002-08-07 Method for treating the cases of post-inflammation bullous keratopathy

Country Status (1)

Country Link
RU (1) RU2218896C1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2270025C1 (en) * 2004-07-05 2006-02-20 Владимир Иванович Братко Method for treating diabetic retinopathy
RU2413528C2 (en) 2007-01-18 2011-03-10 Открытое Акционерное Общество "Валента Фармацевтика" Exenatide and dalargin drug for treating diabetes, adminisration and therapy
RU2343885C1 (en) * 2007-04-17 2009-01-20 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию" Method of treatment of subepithelial crape of cornea after photorefractive keratectomy
RU2672888C1 (en) 2018-04-18 2018-11-20 Пивипи Лабс Пте. Лтд. Anti-viral immunotropic agent for treatment of arvi
RU2687485C1 (en) 2018-09-12 2019-05-14 Пивипи Лабс Пте. Лтд. Agent for therapy of wound and burn skin lesions
WO2021211006A1 (en) 2020-04-13 2021-10-21 Federal State Budgetary Institution Center Of Biomedical Technologies Of Federal Medical And Biological Agency Inhaled hexapeptide for treating interleukin-6 related respiratory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2102949C1 (en) * 1994-04-26 1998-01-27 Новосибирский филиал МНТК "Микрохирургия глаза" Method for treating postoperative ophthalmosurgical complications
RU2165747C1 (en) * 2000-02-08 2001-04-27 Каспаров Аркадий Александрович Method for treating the cases of post-inflammation bullous keratopathy

Also Published As

Publication number Publication date
RU2218896C1 (en) 2003-12-20

Similar Documents

Publication Publication Date Title
RU2006101225A (en) MORANTINE ORAL DOSAGE FORMS
US20130039976A1 (en) Sodium channel blocker for treatment of loss of superficial sensitivity
KR950703951A (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC
RU2012133528A (en) METHOD FOR TREATING AN AUTOIMMUNE DEMIELINIZING DISEASE OF THE CENTRAL NERVOUS SYSTEM (OPTIONS)
RU2010109359A (en) AZITROMYCIN FOR TREATMENT OF SKIN DISEASES
ATE405272T1 (en) TREATMENT OF T-CELL LYMPHOMA USING 10-PROPARGYL-10-DEAZAAMINOPTERIN
RU2002120894A (en) A method for the treatment of post-inflammatory bullous keratopathy
RU2002122084A (en) COMBINATION OF MEDICINES, INCLUDING MIRTAZAPINE, FOR THE TREATMENT OF DEPRESSION AND RELATED DISORDERS
EP1977745A1 (en) Method for the treatment of incontinence
RU2007119545A (en) PEGLIATED LIPOSOMAL DOXORUBICIN IN COMBINATION WITH ECTEINASCIDIN 743 (ECTEINESCIDIN 743)
RU2009101026A (en) APPLICATION OF THYMOSINE-ALPHA-1 FOR PRODUCING A MEDICINE FOR TREATING MALIGNANT MELANOMA IN STAGE IV
RU2000101091A (en) METHOD FOR TREATING DYSTROPHIC DISEASES OF THE RETAIL AND VISUAL NERVE
JPH045231A (en) Analgesic for chronic pain
CO6331430A2 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A KETOROLACO SALT AND VITAMINS OF COMPLEX B FOR THE TREATMENT OF NEURALGIA
RU2002120168A (en) A method for the treatment of ischemic eye diseases
SU1706624A1 (en) Method for curing opiumism and morphinism
RU2440812C1 (en) Method of treating hypotonic dysphonias
RU2004111044A (en) DRUG FOR TREATMENT OF A HEMORRHAGIC STROKE AND METHOD FOR TREATING A HEMORRHAGIC STROKE
Abyad Cobalamin Injection: Is it Useful in Lumbosacral Diseases?
Graham et al. Dequalinium in myasthenia gravis
RU2002135261A (en) MEANS FOR IMPROVING REGIONAL TRANSPORT OF MEDICINES TO THE INJURY CENTER, METHOD FOR ADMINISTRATION AND METHOD FOR TREATMENT OF INFLAMMATORY DISEASES
GB2095992A (en) Psycotropic drugs containing caerulein
RU2025131206A (en) IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS
RU2025131205A (en) IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS
RU2021119487A (en) Combination drug with antiviral effect for the prevention of infection with SARS-CoV-2

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090808